BioE News and Events

upcoming bioe events
Events
Sep 22
Department of Bioengineering PhD Dissertation Defense: Will Skinner 1:00 p.m.

Will Skinner, a PhD Candidate in Bioengineering at the University of Oregon’s Knight Campus, will present his dissertation, “Developing a Magnetoelastic...
Department of Bioengineering PhD Dissertation Defense: Will Skinner
September 22
1:00–2:00 p.m.
Phil and Penny Knight Campus for Accelerating Scientific Impact Beetham Family Seminar Room

Will Skinner, a PhD Candidate in Bioengineering at the University of Oregon’s Knight Campus, will present his dissertation, “Developing a Magnetoelastic Monitoring System for Tracking Cell Density and Growth Kinetics in Real Time.” This presentation also serves as the opening seminar in the 2025–26 Department of Bioengineering Seminar Series. 

BIOE Science Seminars 

UO SCIENCE SEMINARs
bioe news

Knight Campus Ph.D. candidate Rose Hulsey-Vincent has been awarded a competitive National Institutes of Health (NIH) Individual Predoctoral Fellowship (F31) to support her research on the neural basis of song in canary birds.

The Department of Bioengineering’s New Research Experiences for Undergraduates (REU) program offers mentorship, DEI-focused professional development, and momentum for rising scientists

New technology from the University of Oregon’s Knight Campus could help build large, biological datasets needed for machine learning to predict and prevent cancer, diseases, and bacteria resistant to antibiotics before they even emerge.

MORE BIOE NEWS »

event videos

   
Science Knight Out with Jim Hutchison
How can chemistry help build a better and more sustainable future? That question has long been on Jim Hutchison’s mind.
Meet Kylie Williams
Kylie Williams is making history as the first University of Oregon student to earn a degree in engineering — and one of the first-ever PhD graduates from the Knight Campus’ Department of Bioengineering!
Entrepreneurship Speaker Series with Elliot Reed
Discover the high-stakes journey of commercializing disruptive technologies from research institutions to thriving businesses.
Distinguished Lecture Series with David Mooney
David Mooney discusses how T cell-based therapies are revolutionizing the treatment of some types of cancer, but currently suffer from a number of limitations.